| Modality | Indication | Targets | Stage | Company | Project No. | Detail | |
|---|---|---|---|---|---|---|---|
| 1 | Completion of Phase 1 Clinical Trial and IND Approval of Phase 2a Clinical Trial for VTB-10, a First-in-Class Treatment for Pulmonary Arterial Hypertension | ||||||
| Small molecules | PAH (Pulmonary Arterial Hypertension) | Peroxiredoxin 2 (PRX2) | Phase 1 | VASTHERA Co. Ltd. | RS-2026-25501944 | ||
| 2 | |||||||
| Antibody | Pulmonary hypertension | KARS1 | Phase 1 | Zymedi | RS-2023-00283541 | ||